Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease

BACKGROUND: Butyrate-producing gut bacteria are reduced in patients with active inflammatory bowel disease (IBD), supporting the hypothesis that butyrate supplementation may be beneficial in this setting. Nonetheless, earlier studies suggest that the oxidation of butyrate in IBD patients is altered....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Inflamm Bowel Dis
Главные авторы: Ferrer-Picón, Elena, Dotti, Isabella, Corraliza, Ana M, Mayorgas, Aida, Esteller, Miriam, Perales, José Carlos, Ricart, Elena, Masamunt, Maria C, Carrasco, Anna, Tristán, Eva, Esteve, Maria, Salas, Azucena
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Original Basic Science Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905302/
https://ncbi.nlm.nih.gov/pubmed/31211831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izz119
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы